Skip to main content
. 2024 Apr 17;18:100639. doi: 10.1016/j.resplu.2024.100639

Fig. 1.

Fig. 1

The two mediation models. IFABP is the exposure and inflammatory biomarkers are mediators in both models. Organ dysfunction is the outcome in Model 1 and 30-day mortality is the outcome in Model 2. Potential confounding factors such as whole-body ischaemia could affect all variables. IFABP: Intestinal Fatty Acid Binding Protein. IL: Interleukin; TCC: terminal complement complex.